首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Benzoic acid-derived nitrones: A new class of potential acetylcholinesterase inhibitors and neuroprotective agents
【24h】

Benzoic acid-derived nitrones: A new class of potential acetylcholinesterase inhibitors and neuroprotective agents

机译:苯甲酸衍生的硝基:一种新的潜在乙酰胆碱酯酶抑制剂和神经保护剂

获取原文
获取原文并翻译 | 示例
           

摘要

The discovery of new chemical entities endowed with potent and selective acetylcholinesterase (AChE) and/or butyrylcholinesterase (BChE) inhibitory activity is still a relevant subject for Alzheimer's disease therapy. Therefore, a small library of benzoic based amide nitrones (compounds 24 to 42) was synthesized and screened toward cholinesterase enzymes. SAR studies showed that the tert-butyl moiety is the most favourable nitrone pattern. In general, tert-butyl derivatives effectively inhibited AChE, being compound 33 the most potent (IC50 = 8.3 +/- 0.3 mu M; Ki 5.2 mu M). The data pointed to a non-competitive inhibition mechanism of action, which was also observed for the standard donepezil. None of compounds showed BChE inhibitory activity. Molecular modelling studies provided insights into the enzyme-inhibitor interactions and rationalised the experimental data, confirming that the binding mode of nitrones 33 and 38 towards AChE has the most favourable binding free energy.
机译:发现具有有效和选择性乙酰胆碱酯酶(ACHE)和/或丁酰基胆碱酯酶(BCHE)抑制活性的新化学实体仍然是阿尔茨海默病治疗的相关主题。 因此,合成并筛选基于苯甲酸的酰胺硝基氨酸(化合物24至42),并筛选朝向胆碱酯酶酶。 SAR研究表明,叔丁基部分是最有利的亚硝石图案。 通常,叔丁基衍生物有效地抑制疼痛,是化合物33最有效的(IC50 = 8.3 +/-0.3μm; ki5.2μm)。 指出的数据指向非竞争性抑制机制,也针对标准的多奈哌齐观察到。 没有一种化合物显示BCHE抑制活性。 分子建模研究提供了酶抑制剂相互作用的见解,并合理化了实验数据,证实亚硝酮33和38朝向疼痛的结合模式具有最有利的无限化能量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号